| Literature DB >> 26051927 |
C C Cohen1, B Cohen2, J Shang2.
Abstract
Contact precautions are widely recommended to prevent multidrug-resistant organism (MDRO) transmission. However, conflicting data exist regarding their effectiveness. Prior systematic reviews examined contact precautions as part of a larger bundled approach, limiting ability to understand their effectiveness. The aim of this review was to characterize the effectiveness of contact precautions alone against transmission of any MDRO among adult acute care patients. Directed by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement, comprehensive searches of four electronic scientific literature databases were conducted for studies published in English from January 2004 to June 2014. Studies were included if interventional, original research, evaluating contact isolation precautions against MDRO transmission among inpatients. Searches returned 284 studies, six of which were included in the review. These studies measured four different MDROs with one study showing a reduction in transmission. Whereas studies were of high quality regarding outcome operationalization and statistical analyses, overall quality was moderate to low due to poor intervention description, population characterization and potential biases. Where compliance was measured (N = 4), it presented a threat to validity because it included select parts of the intervention, ranged from 21% to 87%, and was significantly different across study phases (N = 2). The poor quality of evidence on this topic continues to limit interpretation of these data. Hence, this conflicting body of literature does not constitute evidence for or against contact precautions. We recommend that researchers consider power calculation, compliance monitoring, non-equivalent concurrent controls when designing future studies on this topic.Entities:
Keywords: Contact precautions; Infection control; Infection prevention; Multidrug-resistant organism; Nosocomial
Mesh:
Year: 2015 PMID: 26051927 PMCID: PMC4486607 DOI: 10.1016/j.jhin.2015.05.003
Source DB: PubMed Journal: J Hosp Infect ISSN: 0195-6701 Impact factor: 3.926
Figure 1Flow diagram of search results and eligibility analysis. Boxes on the left represent stages of evaluation of the publication returned through electronic database searches. The boxes on the right outline the number of articles excluded by the primary reason for exclusion. MDRO, multidrug-resistant organism; IP, infection prevention.
Summary of key characteristics of publications included in the systematic review
| Article | Study design | Setting and population | Intervention and comparison | Primary outcome | Time horizon (dates) | Key conclusions |
|---|---|---|---|---|---|---|
| Bearman | One group pretest–post-test (two intervention phases) | Medical ICU at academic hospital (USA) | Contact isolation (phase 1) Universal gloving (phase 2) | Prevalence and incidence of MRSA or VRE colonization or infection | Phase 1: three months Phase 2: three months (dates not stated) | No differences in the proportion of patients acquiring VRE (14% vs 18%, |
| Bearman | One group pretest–post-test (two intervention phases) | Surgical ICU at academic hospital (USA) | Contact isolation (phase 1) Universal gloving (phase 2) | Prevalence of MRSA or VRE | Phase 1: six months Phase 2: six months (September 2008–September 2009) | Compared with contact precautions, universal gloving with emollient-impregnated gloves, no statistically significant change in the rates of device-associated infection, CDI, or patient MDRO acquisition was observed |
| Cepeda | Repeated treatment | All inpatients with stay >12 h in three medical–surgical ICUs of two academic hospitals (Great Britain) | Gowning and gloving, single room isolation (phases 1 and 3) Gowning and gloving, no single room isolation (phase 2) | Incidence of MRSA colonization or infection | Phase 1: three months Phase 2: six months Phase 3: three months (June 2000 to June 2001) | Risks of acquiring MRSA were similar in the move and non-move phases; combined hazard ratio 0.73 (95% CI: 0.49–1.10), |
| Cheng | One group pretest–post-test with non-equivalent, concurrent control (three phases) | Patients of an ICU in one university-affiliated teaching hospital (Hong Kong) | Cohorting (phase 1) Single room isolation and contact precautions (phase 2) Single room isolation with hand hygiene campaign (phase 3) | ‘Changes in the trend or level of incidence density of ICU onset infection due to MRSA’ (p. 3) | Phase 1: 27 months Phase 2: 27 months Phase 3: 35 months (January 2002–June 2009) | No difference in level or trend change of the incidence density of ICU onset infections due to MRSA and ESBL-producing organisms across different phases during the study period |
| Cohen | One group pretest–post-test (four intervention phases) | All inpatients of a tertiary care medical centre (Israel) | Contact precautions (phase 1) Cohorting patients and staff and roommate screening (phase 2) Phase 2 plus ICU active surveillance (phase 3) Phase 3 plus ED active surveillance (phase 4) | CRKP colonization or infection ‘episodes’ | Phase 1: one year Phase 2: one year Phase 3: 15 months Phase 4: seven months (March 2006–March 2009) | Contact precautions alone are not sufficient for controlling an outbreak of CRKP colonization and infection; significant changes in incidence rate corresponding with phases 2 and 3 |
| Gbaguidi-Haore | Repeated treatment | Academic hospital (France) | Contact precautions, or cohorting if single room unavailable (phases 1 and 3) No isolation (phase 2) | Phase 1: three years Phase 2: three years Phase 3: two years (1999–2006) | Implementation of isolation precautions was negatively associated with |
ICU, intensive care unit; MRSA, meticillin-resistant Staphylococcus aureus; VRE, vancomycin-resistant enterococci; CDI, Clostridium difficile infection; MDRO, multidrug-resistant organism; CI, confidence interval; EBSL, extended spectrum β-lactamase; CRKP, carbapenem-resistant Klebsiella pneumoniae; ED, emergency department; RR, risk ratio.
Quality assessment results for each included papera
| Quality criterion | Bearman | Bearman | Cepeda | Cheng | Cohen | Gbaguidi-Haore |
|---|---|---|---|---|---|---|
| Representativeness | ||||||
| Study population description | 3 | 2 | 4 | 2 | 2 | 4 |
| Inclusion/exclusion criteria | 1 | 1 | 4 | 1 | 1 | 1 |
| Location/setting description | 4 | 4 | 4 | 4 | 4 | 4 |
| Bias and confounding | ||||||
| Study population corresponded to larger population in all key factors | 1 | 1 | 1 | 1 | 1 | 1 |
| Masking | 1 | 1 | 1 | 1 | 1 | 1 |
| How similar was the assessment of outcomes between groups | 1 | 1 | 1 | 1 | 1 | 1 |
| Involvement from author | 1 | 1 | 1 | 1 | 1 | 1 |
| Accounted for confounding interventions | 3 | 2 | 4 | 4 | 2 | 1 |
| Compliance rate | 4 | 3 | 2 | 2 | 2 | 1 |
| Description of intervention | ||||||
| Replication possible given descriptions of intervention | 2 | 3 | 4 | 4 | 3 | 4 |
| Outcomes and follow-up | ||||||
| Outcome assessment procedure clearly defined | 4 | 4 | 4 | 4 | 3 | 3 |
| Groups equivalent in attrition/LOS/death/patient days | 4 | 4 | 4 | 2 | 2 | 4 |
| Statistical analysis | ||||||
| Description and appropriateness of methods | 4 | 4 | 4 | 4 | 4 | 4 |
| Tested differences between groups and variability | 2 | 4 | 4 | 2 | 2 | 4 |
LOS, length of stay.
Key: 1, not applicable; 2, inadequate, not stated; 3, partially adequate; 4, completely adequate. Columns represent each concept outlined on the quality assessment tool and each row represents an included paper.
Added to quality assessment tool described by Aboelela et al. (2006).